Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dapagliflozin on Body Weight in Overweight Women
NCT06383832Phase 4Completed
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in Overweight. Started Oct 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Overweight
Beyond the preview
Go deeper on NCT06383832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06383832.